Citigroup Boosts Cabaletta Bio (NASDAQ:CABA) Price Target to $30.00

Cabaletta Bio (NASDAQ:CABA – Free Report) had its price objective boosted by Citigroup from $26.00 to $30.00 in a research report report published on Thursday, Benzinga reports. Citigroup currently has a buy rating on the stock. CABA has been the subject of a number of other research reports. Wells Fargo & Company lifted their target […]

Related Keywords

Gwendolyn Binder ,Tower Research Capital ,Comerica Bank ,Cabaletta Bio Inc ,Macroview Investment Management ,Wells Fargo Company ,Citigroup ,Jefferies Financial Group ,Cabaletta Bio Company Profile ,Ameritas Investment Partners Inc ,Cantor Fitzgerald ,Cabaletta Bio ,Free Report ,Financial Group ,Research Capital ,Investment Management ,Ameritas Investment Partners ,Get Free Report ,Cabaletta Bio Daily ,